The intravenous therapy utilizes the venous devices to administer drug, fluids, nutrition, and others in the body of the patient suffering from the chronic disease or conditions. The devices are available in two types such as peripheral intravenous and central venous access devices. These devices gives benefits such as stability, rapid hemodilution, safety, blood sampling, mulitlumen configurations and home intravenous therapy.

The intravenous therapy and vein access market is anticipated to grow in the forecast period owing to key factors such as rise in the surgical procedures for accidental cases, increase in the chronic diseases, rise in the healthcare expenditure and more. The market players may experience the growth opportunities due to the rise in the demand for the vascular devices.

The "Global Intravenous Therapy and Vein Access Market Analysis to 2028" is a specialized and in-depth study of the medical device industry with a focus on the global market trend. The report aims to provide an overview of global intravenous therapy and vein access market with detailed market segmentation by product type, application, end user, and geography. The global intravenous therapy and vein access market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading Intravenous Therapy and Vein Access market players and offers key trends and opportunities in the market.

The global intravenous therapy and vein access market is segmented on the basis of product type, application and end user. Based product type, the market is segmented as peripheral vascular access devices, central vascular access devices, infusion pumps and accessories. Based on the application the market is segmented as drug administration, fluid & nutrition administration, blood transfusion and others. On the basis of the end user the market is segmented as hospitals & clinics, ambulatory care centers and others.

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global intravenous therapy and vein access market based on product type, application and end user. It also provides market size and forecast till 2028 for overall market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The intravenous therapy and vein access market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 13 countries globally along with current trend and opportunities prevailing in the region.

North America is expected to contribute to the largest share in the intravenous therapy and vein access market in the forecast period, due to the advancement in the technology for medical devices, cost-effectiveness, healthcare facilities and others. Likewise, the Asia Pacific region is expected to be the fastest growing region due to the awareness in the benefits of the IV therapy and development in the home care settings for the intravenous therapy.

The report analyzes factors affecting intravenous therapy and vein access market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Intravenous Therapy and Vein Access market in these regions.

The report also includes the profiles of key intravenous therapy and vein access companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years. Some of the key players operating in the intravenous therapy and vein access market include, B. Braun Melsungen AG, Smiths Medical, Becton, Dickinson and Company, Terumo Corporation, Medtronic, NIPRO Medical Corporation, Teleflex Incorporated, Edwards Lifesciences Corporation, AngioDynamics and Ameco Medical.